Article Information
History
- March 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David J McLernon1,*,
- Daniele Giardiello2,3,4,
- Ben Van Calster3,5,
- Laure Wynants6,
- Nan van Geloven3,
- Maarten van Smeden7,
- Terry Therneau8,
- Ewout W Steyerberg3 and
- topic groups 6 and 8 of the STRATOS Initiative
- 1Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- 2Netherlands Cancer Institute, Amsterdam, the Netherlands
- 3Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
- 4Institute of Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck, Bolzano, Italy
- 5Department of Development and Regeneration, KU Leuven
- 6School for Public Health and Primary Care, Maastricht University
- 7Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 8Department of Quantitative Health Sciences, Mayo Clinic, Rochester MN, USA
- ↵*Corresponding author
: David McLernon, Polwarth Building, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK, AB25 2ZD; Tel: +441224437152; Email: d.mclernon{at}abdn.ac.uk; Twitter: @davemclernon
Posted March 18, 2022.
Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models
